Convergence of Biotechnology Research
Fundamental to the success of the Michael Smith Laboratories has been the establishment of internationally-recognized research programs. Research conducted at the Michael Smith Laboratories include the development of the world’s first vaccine to reduce the spread of E. coli by cattle, the decoding of the DNA of tree-killing fungus found in the mouth of mountain pine beetles, and developing innovative drugs to treat chronic pain and other therapies. This research has been made possible by the grants received from provincial and federal programs, partnering organizations, as well as from our generous donors.
The Michael Smith Laboratories is an interdisciplinary unit that brings together biologists and engineers to discover innovative solutions to problems of societal importance. The research at the Michael Smith Laboratories is diverse with faculty members converging on unifying research questions to effectively address significant issues in today's world.